American Dream “Shop for Good” Day to Benefit Tackle Kids Cancer

November 30, 2023

In the spirit of giving back this holiday season, American Dream, the premier retail, entertainment and dining destination, will partner with Hackensack Meridian Children’s Health to host a “Shop for Good” day. The property’s retailers, attractions and restaurants will donate a percentage of sales to Tackle Kids Cancer (TKC), a philanthropic initiative that raises money […]

Read More

#TeamTKC NYC Marathon Runners Raise Record $150,000

November 10, 2023

On Sunday, November 5, 2023, #TeamTKC, Tackle Kids Cancer’s running team, represented our organization at the 2023 TCS New York City Marathon. This year, #TeamTKC raised more than $150,000 for Tackle Kids Cancer – a record total for our marathon team! As an Official Charity Partner of the prestigious marathon, our runners celebrate milestones, honor […]

Read More

Shining a Light on the Fight Against Childhood Cancer

September 8, 2023

Every three minutes, a child is diagnosed with cancer and only 4% of our federal budget supports pediatric cancer research, which is why the work of Tackle Kids Cancer is critical.  During Childhood Cancer Awareness Month, we are incredibly grateful to all of our friends and partners who walk alongside Tackle Kids Cancer in our […]

Read More

TKC My Cause My Cleats 2022

TKC MVP Ella Designs Eli Manning’s My Cause My Cleats

December 1, 2022

During Week 13 of the 2022 National Football League (NFL) season, players and personnel are welcomed to reveal their passions beyond the game and wear their hearts on their feet through the My Cause My Cleats initiative. This year, Eli Manning, former New York Giants quarterback and two-time Super Bowl Champion, has chosen Tackle Kids […]

Read More

Meet Kenda

September 14, 2022

Kenda is a cheerful 9 year-old excited for a great year in 4th grade. With the help of Derek Hanson, M.D., Director of Pediatric Neuro-oncology, she has much to look forward to.   In 2016, at the age of three, Kenda was diagnosed with a brain tumor. At the time, the family was living in Egypt.  […]

Read More

Abby and Ella

Abby and Ella: A Sister Story

September 7, 2022

Having a family member with cancer is tough. There are so many questions and fears, it is difficult for adults to wrap their heads around. When Abby, then 8 years old, learned her older sister had cancer she was understandably confused and concerned. “In the beginning it was very hard for Abby to understand how […]

Read More

Meet Addie

Hackensack Meridian Joseph M. Sanzari Children’s Hospital One of Only 12 U.S. Hospitals Offering PNOC Clinical Trial for Brain Cancer

July 1, 2022

A new clinical trial is being offered for children and young adults with recurrent or progressive high-grade glioma (HGG) at Joseph M. Sanzari Children’s Hospital. As a member of the Pacific Pediatric Neuro-Oncology Consortium (PNOC), our hospital is participating in this groundbreaking PNOC trial studying the treatment of HGG, an aggressive, fast-growing type of brain […]

Read More

Eli’s Halftime Report

May 4, 2021

The April 11th Knicks game had a special guest during halftime — none other than retired New York Giants quarterback and #TeamTKC Captain Eli Manning! Eli appeared on both the pre-game show and halftime report to speak with anchor Bill Pidto about Tackle Kids Cancer’s newest fundraising campaign Team TKC: Powered by Eli’s Challenge. The […]

Read More

Penny’s Wish

May 3, 2021

When two-year-old Tackle Kids Cancer (TKC) MVP (most valiant patient) Penelope came to Hackensack Meridian Children’s Health Children’s Cancer Institute last summer, team members were blown away by her energetic spirit and bright smile. She loved to sing and was happy to show off her dance moves to anyone who was willing to watch. Sadly, […]

Read More

The Children’s Cancer Institute Launches Groundbreaking Trial for Pediatric Brain Cancer Patients

September 11, 2020

The Children’s Cancer Institute at the Joseph M. Sanzari Children’s Hospital has officially launched a new study for children with aggressive brain tumors. The 2-hydroxoleic acid study will advance much-needed research in the area of pediatric brain cancer. In conjunction with the pharmaceutical company Laminar Pharma, and with the support of the Matthew Larson Foundation […]

Read More